SR蛋白家族对肿瘤发生发展影响的研究进展(5)
[26] Long J，Caceres J.The SR protein family of splicing factors：master regulators of gene expression[J].Biochemical Journal，2009，417(1)：15.
[27] Das S，Olga Anczuków，Akerman M，et al.Oncogenic Splicing Factor SRSF1 Is a Critical Transcriptional Target of MYC[J].Cell Reports，2012，1(2)：110-117.
[28] Cohen-Eliav M，Golan-Gerstl R，Siegfried Z，et al.The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers[J].The Journal of Pathology，2013，229(4)：630-639.
[29] Luo C，Cheng Y，Liu Y，et al.SRSF2 Regulates Alternative Splicing to Drive Hepatocellular Carcinoma Development[J].Cancer Research，2017，77(5)：1168-1178.
[30] Xu X，Yang D，Ding J H，et al.ASF/SF2-regulated CaMKIIdelta alternative splicing temporally reprograms excitation-contraction coupling in cardiac muscle[J].Cell，2005，120(1)：59-72.
[31] Wang H Y，Xu X，Ding J H，et al.SC35 plays a role in T cell development and alternative splicing of CD45[J].Mol Cell，2001，7(2)：331-342.
[32] Cheng Y，Luo C，Wu W，et al.Liver-specific deletion of SRSF2 caused acute liver failure and early death in mice[J].Molecular and Cellular Biology，2016，36(11)：MCB.01071-15.
[33] Supriya S，Magda L，Hassan J，et al.Deletion of splicing factor SRSF3 in hepatocytes predisposes to hepatocellular carcinoma in mice[J].Hepatology，2015，61(1)：171.
(收稿日期：2019-11-07) (本文編辑：程旭然), 百拇医药(李梦仙 俞建昆 温艳萍 吴翰欣 高凌 刘晓晓 邰文琳)
[27] Das S，Olga Anczuków，Akerman M，et al.Oncogenic Splicing Factor SRSF1 Is a Critical Transcriptional Target of MYC[J].Cell Reports，2012，1(2)：110-117.
[28] Cohen-Eliav M，Golan-Gerstl R，Siegfried Z，et al.The splicing factor SRSF6 is amplified and is an oncoprotein in lung and colon cancers[J].The Journal of Pathology，2013，229(4)：630-639.
[29] Luo C，Cheng Y，Liu Y，et al.SRSF2 Regulates Alternative Splicing to Drive Hepatocellular Carcinoma Development[J].Cancer Research，2017，77(5)：1168-1178.
[30] Xu X，Yang D，Ding J H，et al.ASF/SF2-regulated CaMKIIdelta alternative splicing temporally reprograms excitation-contraction coupling in cardiac muscle[J].Cell，2005，120(1)：59-72.
[31] Wang H Y，Xu X，Ding J H，et al.SC35 plays a role in T cell development and alternative splicing of CD45[J].Mol Cell，2001，7(2)：331-342.
[32] Cheng Y，Luo C，Wu W，et al.Liver-specific deletion of SRSF2 caused acute liver failure and early death in mice[J].Molecular and Cellular Biology，2016，36(11)：MCB.01071-15.
[33] Supriya S，Magda L，Hassan J，et al.Deletion of splicing factor SRSF3 in hepatocytes predisposes to hepatocellular carcinoma in mice[J].Hepatology，2015，61(1)：171.
(收稿日期：2019-11-07) (本文編辑：程旭然), 百拇医药(李梦仙 俞建昆 温艳萍 吴翰欣 高凌 刘晓晓 邰文琳)